DK3077544T3 - Rationelt-baseret design af en målrettet terapi til cancer - Google Patents
Rationelt-baseret design af en målrettet terapi til cancer Download PDFInfo
- Publication number
- DK3077544T3 DK3077544T3 DK14867137.3T DK14867137T DK3077544T3 DK 3077544 T3 DK3077544 T3 DK 3077544T3 DK 14867137 T DK14867137 T DK 14867137T DK 3077544 T3 DK3077544 T3 DK 3077544T3
- Authority
- DK
- Denmark
- Prior art keywords
- rational
- cancer
- targeted therapy
- based design
- design
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361911423P | 2013-12-03 | 2013-12-03 | |
PCT/US2014/068373 WO2015084958A1 (en) | 2013-12-03 | 2014-12-03 | Rationale-based design of a targeted therapy for cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3077544T3 true DK3077544T3 (da) | 2019-07-08 |
Family
ID=53274072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14867137.3T DK3077544T3 (da) | 2013-12-03 | 2014-12-03 | Rationelt-baseret design af en målrettet terapi til cancer |
Country Status (9)
Country | Link |
---|---|
US (2) | US9782418B2 (da) |
EP (1) | EP3077544B1 (da) |
CN (1) | CN106029905B (da) |
AU (1) | AU2014360503A1 (da) |
DK (1) | DK3077544T3 (da) |
ES (1) | ES2732445T3 (da) |
LT (1) | LT3077544T (da) |
PT (1) | PT3077544T (da) |
WO (1) | WO2015084958A1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3077544B1 (en) | 2013-12-03 | 2019-04-24 | Celestra Life Science LLC | Rationale-based design of a targeted therapy for cancer |
CN108220242A (zh) * | 2016-12-10 | 2018-06-29 | 中国科学院大连化学物理研究所 | Spop及突变体表达的c4-2稳定细胞系及构建方法 |
CN107299133A (zh) * | 2017-06-09 | 2017-10-27 | 上海长海医院 | 一种前列腺癌的标志物spop及其在指导肿瘤治疗中的应用 |
CN110396544B (zh) * | 2019-06-19 | 2021-12-24 | 山东大学齐鲁医院 | Cul7在胶质瘤诊断、治疗和预后中的应用 |
WO2021007512A1 (en) * | 2019-07-11 | 2021-01-14 | Emory University | Platinum-based chemotherapy, mast binding agents, glucocorticoid receptor (gr) binding agents, and/or hsp90 binding agents for uses in treating cancer |
CN110970087B (zh) * | 2019-12-31 | 2021-08-03 | 华中科技大学 | 一种鉴定调控细胞自噬的功能激酶的方法 |
CN111671760A (zh) * | 2020-06-10 | 2020-09-18 | 谭志荣 | 人参皂苷ck在制备抗结直肠癌药物中的应用 |
EP4237096A1 (en) | 2020-10-28 | 2023-09-06 | Baylor College of Medicine | Targeting of src-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101489562B (zh) * | 2006-07-21 | 2012-04-18 | 赛福伦公司 | 用于治疗脊髓增生病的jak抑制剂 |
US20090203709A1 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor |
GEP20125664B (en) * | 2008-02-26 | 2012-10-10 | Takeda Pharmaceuticals Co | Condensed heterocyclic derivatives and application thereof |
DE102008031699A1 (de) * | 2008-07-04 | 2010-01-14 | Protagen Ag | Markersequenzen für Prostataentzündungserkrankungen, Prostatakarzinom und deren Verwendung |
WO2010021822A2 (en) * | 2008-07-30 | 2010-02-25 | The Regents Of The University Of California | Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites |
US20120282258A1 (en) * | 2009-11-25 | 2012-11-08 | Dana-Farber Cancer Institute, Inc. | Crlf2 in precursor b-cell acute lymphoblastic leukemia |
US9233163B2 (en) * | 2010-12-28 | 2016-01-12 | The Children's Hospital Of Philadelphia | Hydrolytically releasable prodrugs for sustained release nanoparticle formulations |
EP3077544B1 (en) | 2013-12-03 | 2019-04-24 | Celestra Life Science LLC | Rationale-based design of a targeted therapy for cancer |
-
2014
- 2014-12-03 EP EP14867137.3A patent/EP3077544B1/en active Active
- 2014-12-03 CN CN201480074107.9A patent/CN106029905B/zh active Active
- 2014-12-03 WO PCT/US2014/068373 patent/WO2015084958A1/en active Application Filing
- 2014-12-03 LT LTEP14867137.3T patent/LT3077544T/lt unknown
- 2014-12-03 ES ES14867137T patent/ES2732445T3/es active Active
- 2014-12-03 AU AU2014360503A patent/AU2014360503A1/en not_active Abandoned
- 2014-12-03 PT PT14867137T patent/PT3077544T/pt unknown
- 2014-12-03 US US15/101,392 patent/US9782418B2/en active Active
- 2014-12-03 DK DK14867137.3T patent/DK3077544T3/da active
-
2017
- 2017-07-18 US US15/653,480 patent/US10449202B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20160303140A1 (en) | 2016-10-20 |
PT3077544T (pt) | 2019-08-01 |
ES2732445T3 (es) | 2019-11-22 |
WO2015084958A1 (en) | 2015-06-11 |
CN106029905A (zh) | 2016-10-12 |
CN106029905B (zh) | 2020-04-14 |
EP3077544A1 (en) | 2016-10-12 |
US20180117061A1 (en) | 2018-05-03 |
US9782418B2 (en) | 2017-10-10 |
US10449202B2 (en) | 2019-10-22 |
LT3077544T (lt) | 2019-07-10 |
AU2014360503A1 (en) | 2016-06-30 |
EP3077544A4 (en) | 2017-07-05 |
EP3077544B1 (en) | 2019-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3033086T3 (da) | Kombinationsterapi til behandling af cancer | |
DK2897620T3 (da) | Fremgangsmåde til behandling af cancer | |
DK3076976T3 (da) | Fremgangsmåder til behandling af cancer | |
DK3043816T3 (da) | Anti-b7-h1-antistoffer til behandling af tumorer | |
DK3046583T3 (da) | Viruslignende partikelkonjugater til behandling af tumorer | |
DK3030323T3 (da) | Kdm1a-inhibitorer til behandlingen af sygdom | |
DK2968208T3 (da) | Behandling af kataplexi | |
DK3446742T3 (da) | Lysterapienhed | |
DK2981255T3 (da) | Terapeutiske anvendelser af empagliflozin | |
DK2961388T3 (da) | Kombinationer af lægemidler | |
DK3021838T3 (da) | Behandling af fedme | |
BR112015025408A8 (pt) | combinações de drogas para tratar câncer | |
DK3079750T3 (da) | Udskyllelige katetre | |
DK3077544T3 (da) | Rationelt-baseret design af en målrettet terapi til cancer | |
DK2953904T3 (da) | Fremgangsmåde til kontrolleret fremstilling af et biocid | |
DK3007726T3 (da) | Fremgangsmåder til behandling af en tauopati | |
DK3089749T3 (da) | Kombinerede præparater til behandling af cancer | |
DK2992104T3 (da) | Fremgangsmåde til ekspression | |
DK3620198T3 (da) | Udskyllelige katetre | |
DK2767269T3 (da) | Terapeutisk anordning | |
DK2825558T3 (da) | Kombinationsterapi til behandling af ovariecancer | |
UA29750S (uk) | Інгалятор | |
DK2961378T3 (da) | Fremgangsmåder til behandlingen af mitochondrisk sygdom | |
DK3052102T3 (da) | Sammensætninger til behandling af cancere | |
DK3290035T3 (da) | Procaspase-kombinationsterapi til behandling af cancer |